Crawford Lake Capital Management, LLC Insmed Inc Transaction History

Crawford Lake Capital Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 May 14, 2018	SELL	$21.69 - $32.99 $5.4 Million - $8.21 Million	-249,008 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$26.43 - $31.78 $5.79 Million - $6.96 Million	218,926 Added 727.76%	249,008 $7.76 Million
Q3 2017 Nov 14, 2017	BUY	$11.61 - $31.21 $349,252 - $938,859	30,082	30,082 $939,000

453

172M

5.78M

5.15M

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $9.39B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

Get notified when there are updates to the investment portfolio of Crawford Lake Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Crawford Lake Capital Management, LLC with notifications on news.